AstraZeneca won't advertise its new indication

Share this article:
AstraZeneca will not run TV or print ads for its recently approved pediatric indication on Nexium. The firm told the Delaware News Journal it would instead partner with patient advocacy groups to inform doctors that the drug is now approved as an acid reflux treatment for children ages 12–17.
Share this article:

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.